Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3271 to 3285 of 9024 results

  1. NICE: backing the healthtech that changes lives

    Following the government’s 10 Year Health Plan for England, we're strengthening our role in getting the best healthtech, including digital tools, diagnostics and medical devices, to patients.

  2. Quality standards advisory committee members

    Read biographies of the members of our quality standards advisory committee.

  3. Further information about MTAC registration and meetings

    More detail about Medical Technologies Advisory Committee (MTAC) registration, meeting arrangements and types of attendee.

  4. Further information about IPAC registration and meetings

    More detail about Interventional Procedures Advisory Committee (IPAC) registration, meeting arrangements and types of attendee.

  5. Further information about DAC registration and meetings

    More detail about Diagnostics Advisory Committee (DAC) registration, meeting arrangements and types of attendee.

  6. NICE International

    Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care

  7. Kidney conditions: CKD and SGLT2 inhibitors (IND324)

    This indicator covers the percentage of patients on the CKD register who are treated with an SGLT-2 inhibitor if they have: type 2 diabetes, or no type 2 diabetes and an eGFR 20 ml/min/1.73 m2 to 44 ml/min/1.73 m2 and are currently treated with an ACE inhibitor or angiotensin receptor blocker (ARB) (unless these are contraindicated) or an eGFR 45 ml/min/1.73 m2 to 59 ml/min/1.73 m2, are currently treated with an ACE inhibitor or ARB (unless these are contraindicated) and have a urine albumin-to-creatinine ratio (ACR) of 22.6 mg/mmol or more. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

  8. Diabetes: annual retinal screening (IND137)

    This indicator covers the percentage of patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 month. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM98.

  9. Diabetes: ACEi or ARBs (IND134)

    This indicator covers the percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM95.

  10. Published

    The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.

  11. Speaker request

    Home Events...

  12. We care about our staff

    We support the wellbeing of our staff in a number of ways including an employee assistance programme, mental health first aiders and a variety of health and wellbeing activities.

  13. People and communities network application

    Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis

  14. Purchasing steps: direct awards

    A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.

  15. Interventional procedures advisory committee members

    Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.